Aromatic Silane Platinum Anti-Cancer Drug from Canada
Platinum-based chemotherapy agent with aromatic silane ligands, used in cancer treatment protocols. HTS 2931.90.22.00 classification applies to this aromatic organo-inorganic compound containing silicon and platinum linked to carbon.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Import Tips
• Submit molecular structure diagrams confirming Si-C and Pt coordination bonds
• Comply with cytotoxic drug import protocols including secondary containment packaging
• Verify against List 1 chemicals if platinum complex has precursor potential